loading

Who We Are

Oviya MedSafe is a global Pharmacovigilance Consulting & Drug Safety Services company incorporated in India in 2012 and in the United Kingdom in 2014, offering advisory and outsourced support to the pharmaceutical industry. Oviya MedSafe is backed by 50 years of collective intelligence of its founding groups and works with renowned pharmaceutical companies and marketing authorization holders in various parts of the world.

Oviya MedSafe provides end-to-end global drug safety support (combined with regulatory-compliant drug safety database access, as required) to pharmaceutical companies with mature pharmacovigilance systems. More importantly, Oviya MedSafe comprehensively consults to generic pharmaceutical companies across the globe to help them constantly evolve their pharmacovigilance departments to be in line with the regulations pertinent to their market presence.

Read More

Our Services

PHARMACOVIGILANCE CONSULTING

Oviya MedSafe offers comprehensive global pharmacovigilance consulting solutions through regulatory compliance, higher productivity and strategic drug safety outcomes. Oviya MedSafe has the broad-based experience in pharmacovigilance domain to help you address product safety concerns in a confident, proactive manner, and operating experience to provide unparalleled support to our clients.

Read More

DRUG SAFETY SERVICES

With in-depth expertise of safety reporting in clinical studies and post-marketing surveillance, Oviya MedSafe provide comprehensive global drug safety services.From individual customized stand-alone services to diverse offerings, Oviya MedSafe provides solutions specific to the requirements of our clients.

Read More

News & Events

  • 31

    Jul

    Oviya MedSafe – Redefining Leadership in Pharmacovigilance

    July 2016 edition of our newsletter

    Continue Reading...
  • 30

    Jun

    Oviya MedSafe – Brexit, EU Clientele & Indian Pharmacovigilance

    June 2016 edition of our newsletter

    Continue Reading...
  • 31

    May

    Oviya MedSafe – DIA Experience, Article with PvPI & Indian Pharmacovigilance Day 2016

    May 2016 edition of our newsletter

    Continue Reading...
  • 30

    Apr

    Oviya MedSafe excels in Pharmacovigilance of Patient Support Programmes & Market Research Programmes

    April 2016 edition of our newsletter

    Continue Reading...
  • 31

    Mar

    Oviya MedSafe – UK FPM Article, Indian Pharmacovigilance Legislation & DIA Speakership

    March 2016 edition of our newsletter

    Continue Reading...
  • 29

    Feb

    Oviya MedSafe – XML-E2B Reporting of ICSRs by Industry to Pharmacovigilance Programme of India

    February 2016 edition of our newsletter

    Continue Reading...
  • 31

    Jan

    Oviya MedSafe supports MAHs with pharmacovigilance obligations related to EMA MLM

    January 2016 edition of our newsletter

    Continue Reading...
  • 31

    Dec

    Oviya MedSafe – Bengaluru Pharmacovigilance Workshop & TiE Coimbatore’s d-Healthcare Event

    December 2015 edition of our newsletter

    Continue Reading...
  • 30

    Nov

    Oviya MedSafe – Asian Pharmacovigilance, Indian Emergence & European Compliance

    November 2015 edition of our newsletter

    Continue Reading...
  • 02

    Nov

    Oviya MedSafe invited as Event Partner for 6th Annual Pharmacovigilance Asia 2015, Singapore

    Conference & workshops to be held between 17th and 20th November 2015

    Continue Reading...
View All